Press Releases

Press Release

Announcement of the creation of Sepul Bio Business Unit

Théa, the leading European eye care group , is pleased to announce the creation of Sepul Bio, a business unit dedicated to the development of inherited retinal diseases (IRDs) based on RNA therapy. Operated by experts in the field, Sepul Bio is in charge of the late stage development of two cutting edge ophthalmic products recently acquired from ProQR , Sepofarsen and Ultevursen, and will work with Théa's teams to support all aspects of the project.

Learn more